Publicaciones en colaboración con investigadores/as de Oregon Health & Science University (19)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Analysis of the hikikomori phenomenon – an international infodemiology study of Twitter data in Portuguese

    BMC Public Health, Vol. 24, Núm. 1

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

    Leukemia, Vol. 35, Núm. 1, pp. 18-30

  3. Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 6, pp. 1369-1381

  4. When and How To Use Endoscopic Tattooing in the Colon: An International Delphi Agreement

    Clinical Gastroenterology and Hepatology, Vol. 19, Núm. 5, pp. 1038-1050

2020

  1. Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus

    HPB, Vol. 22, Núm. 10, pp. 1429-1441

2016

  1. Immunodynamics: A cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

    Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1

  2. Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015

    Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1

2015

  1. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

    Biology of Blood and Marrow Transplantation, Vol. 21, Núm. 12, pp. 2039-2051

  2. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

    Nature Medicine, Vol. 21, Núm. 6, pp. 555-559

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013

    Journal of Translational Medicine, Vol. 12, Núm. 1

2012

  1. Basal insulin and cardiovascular and other outcomes in dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 319-328

  2. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 309-318

  3. Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

    British Journal of Cancer, Vol. 107, Núm. 5, pp. 808-813

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

2002

  1. NH2-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer

    Clinical Cancer Research, Vol. 8, Núm. 2, pp. 347-353